We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Max
Most interesting I think it was from a phase 2 trial. That would be great if we could do that and fits in with the 2026 deadline.
Watch this space
Thanks
With the approval, Day One received a rare pediatric disease priority review voucher from the FDA
The one trade is a nonsense. I have seen stocks with 20 x 1 trades in a day and numerous other single digit trades.
The small trades or a dump of trades at the same time are usually liquidity trades by the MM or broker to move the SP or to hold it up.
There is some reference to them here in the LSE handbook.
‘Definition: market making incentive schemes that the Exchange is mandated to offer under Article 48(2)(b) of MiFID and Article 1 of Commission Delegated Regulation (EU) 2017/578
Page 58 covers it and also ALGO trades.
https://docs.londonstockexchange.com/sites/default/files/documents/rules-lse.pdf
MiFID2 MM agmt tab...
https://docs.londonstockexchange.com/sites/default/files/documents/20200401%20MIT%20&%20TE%20Parameters%20version%207.2.xls
Usual caveats
Trek
Kane - even if my life depended on it I couldn't come up with a reason we have so many pocket money trades each day ie under £10.........just don't understand why?
Well coincidence or not, within 80 mins of the 1 trade we finally have the share price lifting (albeit slightly) for the 1st time in ages. Might sell 1 share myself tomorrow and see if it goes up again....lol.
Just noticed if you click the information button next to the amount paid in the trade list it say ordinary trade executed as an si
So I googled what that is and from what I found it’s to do with the otc ?
Some say the 1 code (1 share trade) means RNS logged
The mythical 1 trade ,
This company needs a partner. Someone to steer it towards growth and presumably to work out what to do with a Phase 2 trial. Also someone who is not as mercurial as the current BOD who are doing all of our heads in.
Kane
I totally get people’s frustrations and I have only been invested for a few years. But my reading of the GaM trial is we seem to be being led by the FDA who seem desperate for it to work. All of that is outside the Board’s control. That is KS and MS doing what they are currently doing. I think somebody said after the latest shenanigans that they had spoke to Mike and he said he just gets on with the IB business. That is what we want him and the team to do. Somewhere at all the conferences somebody will eventually say we want that drug and or the image technology. At that point then it will be up to the board to get the best price available. We all know the share bears no correlation to the value of the company. We now have more universities using IB technology for their trials. Again this can only spread the word to other hospitals etc. The only way the board can make serious money is at some point to sell the whole company or IB. We all hoped it would be the PRD and subsequent voucher acting as the catalyst but that hasn’t occurred yet. But we do know that has a deadline of 2026.
Frustrating, annoying etc but IB keep moving forward.
Hopefully we get some indication of the short/medium range future either this week or next.
Thanks
Unfortunately tyke many others don’t share your optimism as we’ve been here nearly 6 years being strung along with the same old bullcrap. There is always an excuse. Stonechecker , IB stroke, LSN. Now the underperforming sales results will probably blame the non existent code thingy. When in reality the bod signed off last years results with lies in about a step change in sales and no phase 2 without substantial funding from big pharma. Feeding us lies about how they’re working tirelessly to pinpoint the anomaly between their hard work and the undervalued share price.
I’m happy to admit I was foolish enough to buy into their lies and am sitting on a 70 odd percent loss at the moment. With nothing but hope that these crooks will soon enough want to fill their pockets again and capitalise on the almost free shares they acquired at the beginning of the year. The problem is many are in the same situation as me and when even a whiff of breaking even presents it’s self many with grab it and run never to go anywhere near anything these crooks are involved in.
The fact they haven’t bothered to try and justify them robbing shareholders shows they couldn’t care less about us. It wouldn’t surprise me if he doesn’t post any results and we get suspended as this company is not being run for all shareholders just a select few.
BB
Thinking about this scenario
If it does keep happening which others have suggested as well then maybe we should all be doing the same so as to increase share holding for the same valuation.
I personally will not be doing that because I believe we will get a transformational RNS out of the blue and I don’t want to miss out on that chance. We all have to do what we think is the best for ourselves whilst IB does what is best for the patients.
In IB (and the science) I trust.
Thanks
OR
-- Great RNS - new money flows in
-- SP rises
-- BIG sells (what's going on?)
-- Bad RNS - fundraise etc
-- BoD buys up cheap stock after selling higher ...
Happens every year - twice on a Leap Year!
-- BB --
Max
Hopefully news this week but who knows?
So what do we want to hear:
•PRD approved and the company say what is the next step to getting a the voucher.
•EAP up and running
•Zero been resubmitted
•CPT been resubmitted
•GEHC and Catanic sales far exceed expectations
•Grant from Gates Foundation
•Bayer want to buy the company
•Big pharma wants to co-sponsor the trials
Any of those would be positive
Or is it more likely:
•No sales via GEHC etc
•Current partners haven’t renewed their contracts
•KS lab is looking for a new partner
•New fund raise
•PRD has been rejected
All possible
Or
• No news, just the basic accounts and a few special proposals for the AGM.
•new research by crystal and announcement the company shares should be worth 8p so the board will buy ours back for 2p and say we are making 30% on current sp.
Fingers crossed everybody. We should know in the next week or two the short term direction of the company.
Thanks
Good luck
Hopefully news soon !
Hello maximillion69,
Absolutely correct over the 300K 😉
Best, 🐸
Tyke
My call would be the 300k at 11.54 and
25k Were buys
So which of the big transaction were actually buys do we reckon?
Have a good weekend everybody
Thanks
Accounts - I struggle with reading accounts. But also laziness (mine) doesn't help. Thanks for the responses. I will try and make a big effort to spend a bit more focused time on the accounts/results. I suspect there isn't a great deal of £ washing about. I hope I'm wrong.
Evening, IB as a trading entity is profitable, as per the accounts, IQAI loses money due to UK listing costs and directors fees but UK listing required to part fund research and development of products, Dec 23 results will be interesting to see what take up there has been as per interims last August, I would have thought PRD news would have hit now, has been 2 months
I did a few dummy trades today of 100,000 sells and was offered between 1.53 and 1.51 depending on time so all 4 of todays trades were sells and not buys as reported.
Max
Looking at the last week’s trades it does look like 1.57+ are buys and anything around 1.50 are sells. But once again we just don’t know.
Xviolet
If you read the January newsletter (bottom paragraph) we may not have even submitted the revised CPT yet. So I think it may be late this year or early next before we get a code unfortunately. So again we have no idea about revenue.
Thanks
They said they need a CPT code to help with sales. They haven't got it yet. We could get bumpy results...then...in May, the light...????
From a recent RNS...
CPT Code: "Earlier this year, we made the strategic decision to apply for a Current Procedure Terminology (CPT) code specific to the DSC perfusion technology available in IB Neuro. The application is due in early November and a final decision will be made in May 2024. A CPT code will help make for easier buying decisions for healthcare administrators."
Just my thought , all the recent small 212 trades make the spread larger than actual thus harder to determine buys or sells . A lot of recent trades are showing as buys on here but I suspect as with todays trades some are sells. Any thoughts ?